The weight loss drug semaglutide showed significant cardiovascular benefits; Texas and Florida are restricting the promotion of COVID-19 vaccines; some Ohio legislators are seeking to block courts from interpreting the state’s recently passed constitutional amendment that created a right to abortion.
In an international study, the weight loss drug semaglutide (Wegovy) demonstrated a 20% reduction in serious heart problems among individuals with pre-existing heart disease, challenging the perception of obesity medications as purely cosmetic, according to the Associated Press. The research, spanning 17,500 participants across 41 countries, is the first to show that Wegovy not only aids weight loss but also prevents heart-related issues in individuals without diabetes. These findings may reshape treatment guidelines and increase pressure for health insurers to cover obesity medications.
Several US states, including Texas and Florida, are limiting public health departments' ability to promote COVID-19 vaccines, with rules forbidding advertising or recommending the vaccines, according to Kaiser Health News. This trend follows a political shift, with some Republican politicians reversing their positions on COVID-19 vaccines. As vaccine uptake remains low, public health officials fear dire consequences for health outcomes, emphasizing the impact of language changes and political interference on public health initiatives.
Several Ohio Republican lawmakers are advocating to limit the authority of courts to review cases related to the newly passed Issue 1 abortion amendment, claiming "foreign election interference" without evidence, according to The Hill. Issue 1, which passed with 57% of the vote, establishes a constitutional right to reproductive freedom while allowing restrictions after fetal viability. GOP legislators express concerns about the amendment's ambiguity and potential misuse, vowing to consider modifications through legislative channels rather than judicial interpretation.
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More